Thrombopoietin Receptor Agonists [MoA]
Semantic Scholar uses AI to extract papers important to this topic.
Treatment of thrombocytopenia with thrombopoietin receptor agonists (TPORAs) seems to be associated with portal vein… Expand Since its discovery, the thrombopoietin (TPO) pathway has been an important pharmaceutical target for the treatment of… Expand Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated clearance of platelets caused… Expand Very few data exist on the management of adult patients diagnosed with primary immune thrombocytopenia (ITP). The objectives of… Expand Background: The aim of this study was to evaluate the treatment reality for outpatients with immune thrombocytopenia (ITP… Expand Most children with immune thrombocytopenia (ITP) will have spontaneous remission regardless of therapy, while about 20% will go… Expand Thrombopoietin receptor agonists (TRAs) are effective treatments for immune thrombocytopenia (ITP). However, continuous therapy… Expand Thrombopoietin receptor agonists (TPOra) are the only treatments for immune thrombocytopenia (ITP) for which evidence of efficacy… Expand Introduction: Primary immune thrombocytopenia (ITP) is a minor disease for many patients; however, the natural history is… Expand Aim: Thrombopoietin receptor agonists (Tpo increase platelet counts in the majority of chronic autoimmune thrombocytopenia… Expand